Published in Lancet on July 13, 1991
Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut (2000) 2.67
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut (1993) 2.47
The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut (1997) 2.35
Randomised controlled trials in primary care: case study. BMJ (2000) 2.19
The clinical relevance of strain types of Helicobacter pylori. Gut (1997) 1.99
Open access upper gastrointestinal endoscopy. BMJ (1993) 1.91
Diagnosis of Helicobacter pylori infection in adult and pediatric patients by using Pyloriset, a rapid latex agglutination test. J Clin Microbiol (1992) 1.72
Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care. BMJ (2001) 1.56
Role of Helicobacter pylori in gastrointestinal disease: implications for primary care of a revolution in management of dyspepsia. Br J Gen Pract (1995) 1.48
Diagnosis of Helicobacter pylori infection by using pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies. J Clin Microbiol (1993) 1.42
Screening for Helicobacter pylori in dyspepsia. Lancet (1991) 1.39
Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol (1992) 1.38
Evaluation of a commercially available second-generation immunoglobulin G enzyme immunoassay for detection of Helicobacter pylori infection. J Clin Microbiol (1992) 1.38
Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy. Gut (1995) 1.36
Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs. Gut (1993) 1.32
Accuracy of serology for the diagnosis of Helicobacter pylori infection--a comparison of eight kits. J Clin Pathol (1996) 1.27
Is saliva serology useful for the diagnosis of Helicobacter pylori? Gut (1996) 1.25
Serological detection of Helicobacter pylori antibodies in children and their parents. J Clin Microbiol (1994) 1.25
Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease. Gut (1993) 1.24
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut (1994) 1.22
Immunoblot assay for serodiagnosis of Helicobacter pylori infections. J Clin Microbiol (1997) 1.22
Evaluation of Pyloriset Screen, a rapid whole-blood diagnostic test for Helicobacter pylori infection. J Clin Microbiol (1998) 1.14
Urea breath tests in the management of Helicobacter pylori infection. Gut (1998) 1.07
Evaluation of enzyme immunoassay for detection of salivary antibody to Helicobacter pylori. J Clin Microbiol (1996) 1.00
Comparison of two rapid whole-blood tests for Helicobacter pylori infection in Chinese patients. J Clin Microbiol (1998) 1.00
Role of endoscopy and biopsy in the work up of dyspepsia. Gut (2002) 0.95
Laboratory tests for Helicobacter pylori should be more widely available. BMJ (1996) 0.94
Any role left for invasive tests? Histology in clinical practice. Gut (1998) 0.93
Diagnosis of Helicobacter pylori infection in adults and children by using the Malakit Helicobacter pylori, a commercially available enzyme-linked immunosorbent assay. J Clin Microbiol (1993) 0.93
Empirical therapy versus diagnostic tests in gastroesophageal reflux disease: a medical decision analysis. Dig Dis Sci (1998) 0.92
Predicting NSAID related ulcers--assessment of clinical and pathological risk factors and importance of differences in NSAID. Gut (1994) 0.91
Diagnostic tests for Helicobacter pylori: comparison and influence of non-steroidal anti-inflammatory drugs. J Clin Pathol (1992) 0.91
Serodiagnosis of Helicobacter pylori infection: comparison and correlation between enzyme-linked immunosorbent assay and rapid serological test results. J Clin Microbiol (1997) 0.90
Evaluation of Pyloriset Dry, a new rapid agglutination test for Helicobacter pylori antibody detection. J Clin Microbiol (1996) 0.90
Serological detection of Helicobacter pylori by a flow microsphere immunofluorescence assay. J Clin Microbiol (1992) 0.88
Evaluation of a commercially available complement fixation test for diagnosis of Helicobacter pylori infection and for follow-up after antimicrobial therapy. J Clin Microbiol (1992) 0.85
Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive Review. Clin Transl Gastroenterol (2013) 0.81
Age-dependent accuracy of Helicobacter pylori antibody assays for adults, with special emphasis on atrophic gastritis. Clin Diagn Lab Immunol (2004) 0.79
Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance. Yale J Biol Med (1997) 0.78
Performance characteristics of an enzyme-linked immunosorbent assay for determining salivary immunoglobulin G response to Helicobacter pylori. J Clin Microbiol (1999) 0.78
How should Helicobacter pylori negative patients be managed? Gut (1999) 0.78
A rational approach to uninvestigated dyspepsia in primary care: review of the literature. Postgrad Med J (2002) 0.78
Evaluation of a commercial enzyme-linked immunosorbent assay (ELISA) kit for serological diagnosis of Helicobacter pylori infection in a group of non-ulcer dyspepsia sufferers. Postgrad Med J (1993) 0.77
Gastroenterology--I: Gastroduodenal disease and Helicobacter pylori. Postgrad Med J (1994) 0.77
Helicobacter pylori and non-steroidal anti-inflammatory drugs: does infection affect the outcome of NSAID therapy? Yale J Biol Med (1999) 0.76
Validation of a Novel Immunoline Assay for Patient Stratification according to Virulence of the Infecting Helicobacter pylori Strain and Eradication Status. J Immunol Res (2017) 0.75
Screening dyspepsia by serology to Helicobacter pylori in children. Lancet (1991) 0.75
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer. J Clin Pathol (1995) 0.75
Comparison of salivary and serum enzyme immunoassays for the diagnosis of Helicobacter pylori infection. Can J Infect Dis (1998) 0.75
Testing for Helicobacter pylori in primary care: trouble in store? J Epidemiol Community Health (1998) 0.75
Management of uninvestigated dyspepsia: review and commentary. Gut (2002) 0.75
Non-invasive testing for Helicobacter pylori. Postgrad Med J (1999) 0.75
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72
The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet (1993) 6.84
Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet (1991) 6.73
Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86
Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. BMJ (1997) 5.80
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet (1999) 5.36
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol (1998) 5.07
Early endoscopy of oesophagus, stomach, and duodenal bulb in patients with haematemesis and melaena. Br Med J (1973) 4.84
Simplified techniques for identifying Campylobacter pyloridis. J Clin Pathol (1986) 4.74
Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia. Gut (1986) 4.47
Gastric cancer: a curable disease in Britain. BMJ (1993) 4.24
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91
Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut (1991) 3.82
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Campylobacter pyloridis--a new factor in peptic ulcer disease? Gut (1986) 3.26
Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23
Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand J Immunol (1993) 3.22
Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol (1987) 3.21
Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol (1994) 3.16
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Lymphocytic gastritis--relationship to Campylobacter pylori infection. J Pathol (1988) 2.88
Acute folate deficiency in surgical patients on aminoacid/ethanol intravenous nutrition. Lancet (1975) 2.86
Oesophageal achalasia in adolescent women mistaken for anorexia nervosa. BMJ (1992) 2.78
Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60
Observer variation in the histological grading of rectal carcinoma. J Clin Pathol (1983) 2.59
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58
Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut (1993) 2.47
Pancreatography in chronic pancreatitis: international definitions. Gut (1984) 2.37
Early gastric cancer in Europe. Gut (1997) 2.34
Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol (2000) 2.31
Chronic gastritis--a pathogenetic approach. J Pathol (1988) 2.31
Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet (1986) 2.27
Disodium cromoglycate in the treatment of chronic proctitis. Gut (1975) 2.21
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut (1973) 2.21
Effect of cimetidine on the gastric bacterial flora. Lancet (1980) 2.18
Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg (1983) 2.17
Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease. Br Med J (1978) 2.12
Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10
Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol (1986) 2.03
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet (1984) 2.00
PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00
Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99
Dyspepsia: a dilemma for doctors? Lancet (1987) 1.96
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer (1993) 1.93
Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol Suppl (1988) 1.93
Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92
Flat adenomas in the United Kingdom: are treatable cancers being missed? Endoscopy (1998) 1.92
Open access upper gastrointestinal endoscopy. BMJ (1993) 1.91
Immune response to Campylobacter pyloridis. Lancet (1985) 1.86
Immune responses to Helicobacter pylori in children with recurrent abdominal pain. J Clin Pathol (1991) 1.84
Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Gut (1986) 1.83
Gastric cancer, cytotoxin-associated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogst Study Group. Gastroenterology (1999) 1.83